Description générale
Ondansetron is a selective serotonin 5-HT3 antagonist used in the prevention and treatment of nausea and vomiting.
INN
Ondansetron
Codes ATC
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté pour la première fois en 2009
(TRS
958)
pour
Nausea or vomiting
Ajouté en 2011
(TRS
965)
pour
Palliative care
Wikipédia
DrugBank
Recommandations
Section
Medicines for other common symptoms in palliative care
- Parenteral > General injections > IV: 2 mg per mL in 2 mL ampoule (ondansetron base, as hydrochloride)
- Oral > Liquid: 4 mg per 5 mL (ondansetron base)
- Oral > Solid: 4 mg (ondansetron base); 8 mg (ondansetron base)
Indications
Section
Antiemetic medicines
- Parenteral > General injections > IV: 2 mg per mL in 2 mL ampoule (ondansetron base, as hydrochloride)
- Oral > Liquid: 4 mg per 5 mL (ondansetron base)
- Oral > Solid: 4 mg (ondansetron base); 8 mg (ondansetron base); 24 mg (ondansetron base)
Indications